These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 34257565)
41. Tadalafil enhances the therapeutic efficacy of BET inhibitors in hepatocellular carcinoma through activating Hippo pathway. Kong D; Jiang Y; Miao X; Wu Z; Liu H; Gong W Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166267. PubMed ID: 34508829 [TBL] [Abstract][Full Text] [Related]
42. YAP/TAZ: Key Players for Rheumatoid Arthritis Severity by Driving Fibroblast Like Synoviocytes Phenotype and Fibro-Inflammatory Response. Caire R; Audoux E; Courbon G; Michaud E; Petit C; Dalix E; Chafchafi M; Thomas M; Vanden-Bossche A; Navarro L; Linossier MT; Peyroche S; Guignandon A; Vico L; Paul S; Marotte H Front Immunol; 2021; 12():791907. PubMed ID: 34956224 [TBL] [Abstract][Full Text] [Related]
43. Wnt/β-Catenin Signaling Regulates Yap/Taz Activity during Embryonic Development in Zebrafish. Astone M; Tesoriero C; Schiavone M; Facchinello N; Tiso N; Argenton F; Vettori A Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337493 [TBL] [Abstract][Full Text] [Related]
44. Hepatic Hippo signaling inhibits development of hepatocellular carcinoma. Liu Y; Wang X; Yang Y Clin Mol Hepatol; 2020 Oct; 26(4):742-750. PubMed ID: 32981290 [TBL] [Abstract][Full Text] [Related]
45. Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression. Lee NY; Choi MG; Lee EJ; Koo JH Arch Pharm Res; 2024 Jun; 47(6):558-570. PubMed ID: 38874747 [TBL] [Abstract][Full Text] [Related]
46. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma. Shi H; Zou Y; Zhong W; Li Z; Wang X; Yin Y; Li D; Liu Y; Li M J Cancer Res Clin Oncol; 2023 Nov; 149(16):15311-15322. PubMed ID: 37608027 [TBL] [Abstract][Full Text] [Related]
47. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma. Xiao H; Jiang N; Zhou B; Liu Q; Du C Cancer Sci; 2015 Feb; 106(2):151-9. PubMed ID: 25495189 [TBL] [Abstract][Full Text] [Related]
48. YAP/TAZ-mediated regulation of laminin 332 is enabled by β4 integrin repression of ZEB1 to promote ferroptosis resistance. Goel HL; Karner ER; Kumar A; Mukhopadhyay D; Goel S; Mercurio AM J Biol Chem; 2024 Apr; 300(4):107202. PubMed ID: 38508310 [TBL] [Abstract][Full Text] [Related]
49. Hypoxic conditions differentially regulate TAZ and YAP in cancer cells. Yan L; Cai Q; Xu Y Arch Biochem Biophys; 2014 Nov; 562():31-6. PubMed ID: 25078107 [TBL] [Abstract][Full Text] [Related]
50. Therapeutic effects of Chlorella vulgaris on carbon tetrachloride induced liver fibrosis by targeting Hippo signaling pathway and AMPK/FOXO1 axis. Mohseni R; Alavian SM; Sadeghabadi ZA; Heiat M Mol Biol Rep; 2021 Jan; 48(1):117-126. PubMed ID: 33296068 [TBL] [Abstract][Full Text] [Related]
51. A Critical YAP in Malignancy of HCC Is Regulated by Evodiamine. Yun UJ; Bae SJ; Song YR; Kim YW Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163776 [TBL] [Abstract][Full Text] [Related]
52. Traditional Chinese medicine Yiqi Huoxue recipe attenuates hepatic fibrosis via YAP/TAZ signaling. Zhao W; Zhang X; Hou M; Zhang Y; Tang Y; Li L; Dong S; Liu L; Zhao D; Li W; Nan Y Histol Histopathol; 2021 Sep; 36(9):967-979. PubMed ID: 34490599 [TBL] [Abstract][Full Text] [Related]
53. Control of stem cell renewal and fate by YAP and TAZ. Driskill JH; Pan D Nat Rev Mol Cell Biol; 2023 Dec; 24(12):895-911. PubMed ID: 37626124 [TBL] [Abstract][Full Text] [Related]
54. YAP/TAZ maintain the proliferative capacity and structural organization of radial glial cells during brain development. Lavado A; Gangwar R; Paré J; Wan S; Fan Y; Cao X Dev Biol; 2021 Dec; 480():39-49. PubMed ID: 34419458 [TBL] [Abstract][Full Text] [Related]
55. Relation Between Immunohistochemical Expression of Hippo Pathway Effectors and Chronic Hepatitis Induced Fibrosis in Egyptian Patients. Abdallah RA; Shaban MI; Taie DM; Asaad NY; Badr A Turk Patoloji Derg; 2020; 36(1):48-63. PubMed ID: 31282549 [TBL] [Abstract][Full Text] [Related]
56. Combined control of the fibroblast contractile program by YAP and TAZ. Link PA; Choi KM; Diaz Espinosa AM; Jones DL; Gao AY; Haak AJ; Tschumperlin DJ Am J Physiol Lung Cell Mol Physiol; 2022 Jan; 322(1):L23-L32. PubMed ID: 34755530 [TBL] [Abstract][Full Text] [Related]
57. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer. Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813 [TBL] [Abstract][Full Text] [Related]
58. Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes-Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans. Wang H; Song X; Liao H; Wang P; Zhang Y; Che L; Zhang J; Zhou Y; Cigliano A; Ament C; Superville D; Ribback S; Reeves M; Pes GM; Liang B; Wu H; Evert M; Calvisi DF; Zeng Y; Chen X Hepatology; 2021 Jul; 74(1):248-263. PubMed ID: 33368437 [TBL] [Abstract][Full Text] [Related]
59. DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis. Xu S; Yuan Z; Jiang C; Chen W; Li Q; Chen T Adv Sci (Weinh); 2024 Apr; 11(16):e2308531. PubMed ID: 38380551 [TBL] [Abstract][Full Text] [Related]
60. Context-dependent transcriptional regulations of YAP/TAZ in stem cell and differentiation. Luo J; Li P Stem Cell Res Ther; 2022 Jan; 13(1):10. PubMed ID: 35012640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]